Related Experiment Video
Updated: May 2, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 24, 2014
Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients
Sonia Dollfus1, Véronique Olivier, Benoît Chabot
1Department of psychiatry, Centre Esquirol, Centre Hospitalier et Universitaire, avenue de la Côte de Nacre, Caen, 14000, France. dollfus-s@chu-caen.fr
Objective:
To compare the efficacy of two atypical antipsychotic drugs, olanzapine and risperidone, in schizophrenic patients with post-psychotic depression.
Results:
A clinically significant decrease of MADRS scores occurred in patients treated with both drugs for 8 weeks.
Conclusion:
Atypical antipsychotic drugs may be particularly appropriate when treating schizophrenic patients with depression.
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Typical and Atypical Agents
Mania and Antimanic Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications

